Who invested in NeuExcell Therapeutics?
NeuExcell Therapeutics's investors include Innoangel Fund and Foothill Ventures.

United States · Seed startup
Funding summaryUpdated 26 Oct 2026
$15Mraised across 1 round since 2023, from 1 source
From NeuExcell Therapeutics's own website and the SEC filings it signed: 1 founder, 2 on the team.
NeuExcell Therapeutics's investors include Innoangel Fund and Foothill Ventures.
NeuExcell Therapeutics has raised $15M across 1 round since 2023.
NeuExcell Therapeutics's most recent round was a Seed of $15M in May 2023.
Its most recent round, $15M in May 2023, is also its largest on record.
NeuExcell Therapeutics's first round on record, in May 2023, was backed by Innoangel Fund and Foothill Ventures.
NeuExcell Therapeutics's latest named round is a Seed, in May 2023.
NeuExcell Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.